XCBE exhibits critical financial weakness, highlighted by a Piotroski F-Score of 2/9, placing it firmly in the 'Weak' health category. As a shell company, it lacks operational revenue and earnings, but more concerning is the extreme liquidity crisis indicated by a Current Ratio of 0.04 and a deeply negative Price/Book ratio of -1237.50. The absence of an Altman Z-Score and Graham Number reflects a lack of traditional fundamental value. The stock is currently trading near its 52-week high, likely reflecting the trust value of a SPAC rather than business performance.